Skip to main content

Table 2 Trends in surgically resected pancreatic cystic neoplasms

From: Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution

  1997-2000 2001-2004 2005-2008 2009-2013
N 3 (2.7%) 6 (5.4%) 27 (24.3%) 75 (67.6%)
Symptoms, n (%)     
Yes 2 (66.7%) 4 (66.7%) 17 (63.0%) 39 (52.0%)
No 1 (33.3%) 2 (33.3%) 10 (37.0%) 36 (48.0%)
Time interval, months, median (range)* 0.3 (0.2-12.0) 1 (0.2-48.0) 1 (0.1-120.0) 1 (0.02-144.0)
Pancreatic cystic neoplasms, n (%)     
IPMN (intraductal papillary mucinous neoplasm) 0 0 5 (18.5%) 12 (16.0%)
MCN (mucinous cystic neoplasm) 2 (66.7%) 1 (16.7%) 3 (11.1%) 14 (18.7%)
SCN (serous cystic neoplasm) 1 (33.3%) 1 (16.7%) 15 (55.6%) 22 (29.3%)
SPN (solid pseudopapillary neoplasm) 0 4 (66.7%) 4 (14.8%) 27 (36.0%)
  1. *The time lapse from the presentation of symptoms and diagnosis of the cystic lesions of the pancreas.